Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$8,235,287
+$1,817,132 QoQ
Shares Held
6,866
-1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#1,365
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CULLINAN ASSOCIATES INC holds $90,482,569 across 10 Drug Manufacturers - General names. LLY ranks #4 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
177,028 | $44,959,801 | |
| 2 | ABBV |
AbbVie Inc.
|
68,800 | $17,312,832 | |
| 3 | AMGN |
Amgen Inc
|
24,288 | $8,795,170 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
6,866 | $8,235,287 | |
| 5 | MRK |
Merck & Co., Inc.
|
46,620 | $5,990,670 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
40,190 | $2,315,747 | |
| 7 | PFE |
Pfizer Inc
|
51,301 | $1,235,328 | |
| 8 | NVS |
Novartis AG
|
4,700 | $736,584 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,235,287 | 6,866 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $6,418,155 | 6,978 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $8,573,797 | 7,978 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $6,823,509 | 8,943 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $6,524,666 | 8,370 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $7,738,776 | 9,370 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $6,990,460 | 9,055 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $8,297,714 | 9,366 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $8,404,642 | 9,283 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $5,156,318 | 6,628 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $3,683,471 | 6,319 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $3,960,259 | 7,373 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $2,831,701 | 6,038 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,107,911 | 6,138 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $2,428,445 | 6,638 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $1,358,070 | 4,200 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $583,614 | 1,800 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $343,644 | 1,200 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $331,464 | 1,200 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $392,785 | 1,700 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $619,704 | 2,700 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $537,294 | 2,876 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $3,811,731 | 22,576 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $3,348,952 | 22,625 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $4,666,816 | 28,425 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $4,289,916 | 30,925 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||